Intrauterine release of levonorgestrel—a new way of adding progestogen in hormone replacement therapy

Obstetrics and Gynecology

Volumn 79, Issue 6, 1992, Pages 963-967

  Andersson, Kerstin ^a   Mattsson, Lars Åke ^a   Rybo, Göran ^a   Stadberg, Elisabeth ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS NORGESTREL; LEVONORGESTREL;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAVAGINAL DRUG ADMINISTRATION; MENOPAUSE; PRIORITY JOURNAL;

BIOPSY; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENOPAUSE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; UTERINE HEMORRHAGE; UTERUS;

EID: 0026654966     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lindsay R, Hart DM, Clarc DN. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984;63:759-63.
2. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861-7.
3. Persson I, Adami HO, Bergkvist L, et al. Risk of endometrial cancer after treatment with oestrogens alone and in conjunction with progestogens. Results of a prospective study. Br Med J 1989;298:147-51.
4. Whitehead M. The effects of oestrogens and progestogens on the postmenopausal endometrium. Maturitas 1978;1:87-98.
5. Hahn RG. Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors. Am J Obstet Gynecol 1989;161:1854-8.
6. Mattsson L-Å, Cullberg G, Samsioe G. Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints. Matu-ritas 1982;4:95-102.
7. Sporrong T, Hellgren M, Samsioe G, Mattsson L-Å. Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints. Br J Obstet Gynaecol 1988;95:1042-8.
8. Sporrong T, Samsoie G, Larsen S, Mattsson L-Å. A novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy. Maturitas 1989;11:209-15.
9. Nilsson CG, Luukkainen T. Improvement of a d-norgestrel-releasing IUD. Contraception 1977;15:295-306.
10. Nilsson CG. Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing IUD and a Nova-T copper device. Contraception 1977;15:379-87.
11. Andersson K, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990;97:690-4.
12. Schiff I, Sela HK, Cramer D, Tulchinsky D, Ryan KJ. Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril 1982;37:79-82.
13. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975;293: 1167-70.
14. Ferguson K, Hoegh C, Johnson S. Estrogen replacement therapy. A survey of women's knowledge and attitudes. Arch Intern Med 1989;149:133-6.
15. Hammarbäck S, Bäckström T, Holst J, von Schoultz B, Lyrenäs S. Cyclical mood changes as in the premenstrual syndrome during sequential estrogen-progestogen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 1985;64:393-7.
16. Staland B. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas 1981;3:145-51.
17. Hallberg L, Högdahl A-M, Nilsson L, Rybo G. Menstrual blood loss—a population study. Acta Obstet Gynecol Scand 1964;43: 320-52.
18. Magos AL, Brincat M, Studd JWW. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women. Obstet Gynecol 1985;65:496-9.
19. Silverberg SG, Haukkamaa M, Arko H, Nilsson CG, Luukkainen T. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol 1986; 5:235-41.
20. Toivonen J, Luukkainen T, Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: Three years' comparative experience of levonorgestrel-and copper-releasing intrauterine devices. Obstet Gynecol 1991;77:261-4.
21. Luukkainen T, Allonen H, Haukkamaa M, et al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12 month report of a European multicenter study. Contraception 1987;36:169-79.